Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes. Doctors also prescribe it to lower the risk of cardiovascular problems in people with both type 2 diabetes and heart failure ...

Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the skin.

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with ...

Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product’s ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ...

Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product’s ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ...

Bagsværd, Denmark, 4 March 2016 - Novo Nordisk today announced the top-line results from the LEADERtrial, which investigated the cardiovascular safety of Victoza® (liraglutide) over a period of up to ...